Orthopediatrics (NASDAQ:KIDS) Announces Earnings Results

Share on StockTwits

Orthopediatrics (NASDAQ:KIDS) issued its earnings results on Thursday. The company reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.01), Briefing.com reports. Orthopediatrics had a negative net margin of 15.77% and a negative return on equity of 12.92%. The firm had revenue of $20.74 million during the quarter, compared to analysts’ expectations of $19.87 million. During the same quarter last year, the firm earned ($0.15) EPS. The business’s revenue for the quarter was up 31.1% compared to the same quarter last year.

Shares of KIDS traded up $1.58 during trading hours on Friday, hitting $37.50. 125,300 shares of the company were exchanged, compared to its average volume of 74,879. The firm’s 50 day moving average is $36.29 and its 200-day moving average is $36.98. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.75 and a current ratio of 2.53. The company has a market cap of $560.98 million, a PE ratio of -39.06 and a beta of 0.23. Orthopediatrics has a 52 week low of $25.11 and a 52 week high of $47.82.

KIDS has been the topic of a number of recent research reports. BidaskClub downgraded Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Friday. ValuEngine downgraded Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research downgraded Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Piper Jaffray Companies boosted their target price on Orthopediatrics from $40.00 to $44.00 and gave the company an “overweight” rating in a research note on Friday. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $44.40.

Orthopediatrics Company Profile

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

See Also: Are we seeing the beginning of a new bubble?

Earnings History for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Yum! Brands, Inc.  Shares Bought by D.A. Davidson & CO.
Yum! Brands, Inc. Shares Bought by D.A. Davidson & CO.
Rambus Inc.  Shares Purchased by Vaughan Nelson Investment Management L.P.
Rambus Inc. Shares Purchased by Vaughan Nelson Investment Management L.P.
Scholium Group  Trading Down 6.2%
Scholium Group Trading Down 6.2%
Vaughan Nelson Investment Management L.P. Has $20.80 Million Stock Position in AMETEK, Inc.
Vaughan Nelson Investment Management L.P. Has $20.80 Million Stock Position in AMETEK, Inc.
Vaughan Nelson Investment Management L.P. Lowers Stake in Ares Management Corp
Vaughan Nelson Investment Management L.P. Lowers Stake in Ares Management Corp
Goelzer Investment Management Inc. Purchases New Position in Globe Life Inc.
Goelzer Investment Management Inc. Purchases New Position in Globe Life Inc.


 
© 2006-2019 Zolmax.